Itaconate and Its Derivatives Repress Early Myogenesis In Vitro and In Vivo

A Krebs cycle intermediate metabolite, itaconate, has gained attention as a potential antimicrobial and autoimmune disease treatment due to its anti-inflammatory effects. While itaconate and its derivatives pose an attractive therapeutic option for the treatment of inflammatory diseases, the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Tae Seok, Hutchins, Damian C., Mainali, Rabina, Goslen, Kevin H., Quinn, Matthew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898833/
https://www.ncbi.nlm.nih.gov/pubmed/35265064
http://dx.doi.org/10.3389/fimmu.2022.748375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898833/
https://www.ncbi.nlm.nih.gov/pubmed/35265064
http://dx.doi.org/10.3389/fimmu.2022.748375

Ejemplares similares